01Rapid, visual results
A clear result after 10 minutes supports treatment and patient-management decisions while the patient is still in the office.
Acute respiratory infections
Help rule out bacterial infection after 10 minutes with a 99% NPV*
Take a more confident approach to respiratory season with FebriDx®, an instrument-free, CLIA-waived fingerstick test.
FebriDx® provides a clear, objective host-response result that can support diagnostic decisions and strengthen treatment conversations during the visit.
Explore the clinical workflow
Ready forcold & flu
season
99%Negative Predictive Valuefor bacterial infection*
10 minResults during the visitfrom a simple 5 µL fingerstick¹
No instrumentSimple workflowno additional equipment required
0442UPLA reimbursement codefor qualifying use²
MxA + CRPDual-biomarker technologyobjective host-response result³
Built for the respiratory visit
Objective information when symptoms overlap.
Acute respiratory infections are among the most common reasons for physician office visits.⁴˒⁵ FebriDx® supports clinical decision-making during the visit and provides a practical pathway to multi-site adoption.
01
02Designed to fit the visit
The single-use, instrument-free test uses a 5 µL fingerstick sample and fits into the initial respiratory visit.¹
03A practical adoption pathway
A dedicated PLA code helps teams evaluate operational fit and reimbursement considerations across sites.²
Evidence and important information
- FebriDx® U.S. Instructions for Use.
- Centers for Medicare & Medicaid Services, Clinical Laboratory Fee Schedule, HCPCS/PLA Code 0442U.
- Shapiro NI, Self WH, Rosen J, et al. Annals of Medicine. 2018;50(5):420-429.
- Harris AM, Hicks LA, Qaseem A. Annals of Internal Medicine. 2016;164(6):425-434.
- Centers for Disease Control and Prevention. 2018 NAMCS Web Tables.
*See the U.S. Instructions for Use for complete performance data and limitations.For professional use only.
For prescription in vitro diagnostic use. Intended for ages 12–64 with acute respiratory symptoms lasting fewer than 7 days and fever beginning within the past 3 days. Interpret results alongside clinical assessment and other diagnostic findings; the test does not identify a specific pathogen or measure infection severity. A negative result does not eliminate every possibility of bacterial infection. Predictive values depend on the population tested.
Coding information is educational and does not guarantee coverage or payment. Confirm current payer requirements and applicable laboratory certification before billing.